IDO1 and Hepatic fibrosis: These findings suggest an association between the activation of IDO1 and JAK2/STAT3 pathways and the progression of hepatic fibrosis, indicating the potential utility of DSS as a complementary agent for the treatment and prevention of hepatic fibrosis [114].